ES8301898A1 - Un procedimiento para la preparacion de un polipeptido - Google Patents

Un procedimiento para la preparacion de un polipeptido

Info

Publication number
ES8301898A1
ES8301898A1 ES505610A ES505610A ES8301898A1 ES 8301898 A1 ES8301898 A1 ES 8301898A1 ES 505610 A ES505610 A ES 505610A ES 505610 A ES505610 A ES 505610A ES 8301898 A1 ES8301898 A1 ES 8301898A1
Authority
ES
Spain
Prior art keywords
polypeptide
procedure
glu
lys
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES505610A
Other languages
English (en)
Spanish (es)
Other versions
ES505610A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of ES505610A0 publication Critical patent/ES505610A0/es
Publication of ES8301898A1 publication Critical patent/ES8301898A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1019Tetrapeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/062Serum thymic factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/18Thymus derived hormone or factor; related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/28Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES505610A 1980-09-19 1981-09-18 Un procedimiento para la preparacion de un polipeptido Expired ES8301898A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18880480A 1980-09-19 1980-09-19
US06/286,138 US4361673A (en) 1980-09-19 1981-07-27 Polypeptide compositions

Publications (2)

Publication Number Publication Date
ES505610A0 ES505610A0 (es) 1983-01-01
ES8301898A1 true ES8301898A1 (es) 1983-01-01

Family

ID=26884483

Family Applications (1)

Application Number Title Priority Date Filing Date
ES505610A Expired ES8301898A1 (es) 1980-09-19 1981-09-18 Un procedimiento para la preparacion de un polipeptido

Country Status (16)

Country Link
US (1) US4361673A (OSRAM)
EP (1) EP0048573B1 (OSRAM)
KR (1) KR830007516A (OSRAM)
AR (1) AR229034A1 (OSRAM)
AU (1) AU542630B2 (OSRAM)
CA (1) CA1186303A (OSRAM)
DE (1) DE3165244D1 (OSRAM)
DK (1) DK410481A (OSRAM)
ES (1) ES8301898A1 (OSRAM)
FI (1) FI812822L (OSRAM)
GB (1) GB2086910B (OSRAM)
GR (1) GR74352B (OSRAM)
IE (1) IE51557B1 (OSRAM)
IL (1) IL63824A (OSRAM)
PH (1) PH17269A (OSRAM)
PT (1) PT73702B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100974A1 (de) * 1980-01-18 1982-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente enthaltende arzneimittel mit immunregulierender wirkung, und thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente
EP0056594B1 (de) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
US4442031A (en) * 1981-10-15 1984-04-10 Hoffmann-La Roche Inc. Immunopotentiating peptides
US4505853A (en) 1983-11-18 1985-03-19 Ortho Pharmaceutical Corporation Enzyme-resistant immunomodulatory peptides
US4547489A (en) * 1984-06-11 1985-10-15 Ortho Pharmaceutical Corporation Conformationally restricted thymopentin-like compounds
US4629723A (en) * 1984-06-27 1986-12-16 Ortho Pharmaceutical Corporation Potent thymopentin analogs
EP0215805A1 (en) * 1985-01-18 1987-04-01 MERCK PATENT GmbH Immunoregulatory peptides
DK15888D0 (da) * 1988-01-14 1988-01-14 Carlsberg Biotechnology Ltd Enzymatisk fremgangsmaade til fremstilling af immunmodulerende pentapeptider samt mellemprodukter til brug ved fremgangsmaaden
DE68926178T2 (de) * 1988-05-10 1996-11-28 Alpha 1 Biomedicals Inc Festphase-Verfahren zur Gewinnung von Thymosin-alpha-1
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
US5036050A (en) * 1989-01-12 1991-07-30 Immunobiology Research Institute, Inc. Compositions containing thymopentin for topical treatment of skin disorders
IT1244548B (it) * 1991-02-06 1994-07-15 Poli Ind Chimica Spa Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
ES2537785T3 (es) * 2009-05-08 2015-06-12 Sciclone Pharmaceuticals, Inc. Péptidos de alfa timosina como potenciadores de vacunas

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
US4250086A (en) * 1979-11-19 1981-02-10 Ortho Pharmaceutical Corporation Method and composition for preparation of H-SAR-LYS-SAR-GLN-NH2
DE2938420A1 (de) * 1979-09-22 1981-04-09 Hoechst Ag, 6000 Frankfurt Neue peptide und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IL63824A (en) 1985-02-28
FI812822A7 (fi) 1982-03-20
AU542630B2 (en) 1985-02-28
PT73702A (en) 1981-10-01
EP0048573B1 (en) 1984-08-01
EP0048573A2 (en) 1982-03-31
AR229034A1 (es) 1983-05-31
PH17269A (en) 1984-07-03
FI812822L (fi) 1982-03-20
DK410481A (da) 1982-03-20
EP0048573A3 (en) 1982-08-11
KR830007516A (ko) 1983-10-21
GB2086910A (en) 1982-05-19
IE812159L (en) 1982-03-19
US4361673A (en) 1982-11-30
ES505610A0 (es) 1983-01-01
IE51557B1 (en) 1987-01-07
AU7540581A (en) 1982-03-25
IL63824A0 (en) 1981-12-31
PT73702B (en) 1982-12-10
GR74352B (OSRAM) 1984-06-26
GB2086910B (en) 1983-12-21
DE3165244D1 (en) 1984-09-06
CA1186303A (en) 1985-04-30

Similar Documents

Publication Publication Date Title
ES8301898A1 (es) Un procedimiento para la preparacion de un polipeptido
NO923253D0 (no) Fremgangsmaate for fremstilling og anvendelse av 2-piperazinonforbindelser
ATE108438T1 (de) Urethan geschützte aminosäuren-n- carboxyanhydride.
ES2067456T3 (es) Nuevos derivados de aminoacidos, procedimientos para su preparacion y composicion farmaceutica que los comprende.
AR062931A2 (es) Compuestos que se enlazan a y activan un receptor de la trombopoyetina , composicones farmaceuticas que los contienen y su uso para la preparacion de medicamentos
NO167141C (no) Bicykliske aromatiske forbindelser for kosmetisk anvendelse og blandinger som inneholder dem.
DK278383A (da) Fremgangsmaade til fremstilling af et peptid, der indvirker paa menneskers og andre pattedyrs hypofysekirtelfunktion
ES2060654T3 (es) Trigramina - un polipeptido inhibidor de la agregacion plaquetaria.
SE8901552D0 (sv) Acid addition salts of amidated or glycine, their preparation and use
GB9219936D0 (en) Vaccines
DK634389D0 (da) Peptid, dets fremstilling og anvendelse til paavisning af hiv-protease
ATE130312T1 (de) Polypeptid mit sich wiederholenden zelladhäsiven hauptsequenzen.
DE69012901D1 (de) Hämoregulierende Peptide.
ES2038675T3 (es) Un procedimiento para preparar compuestos peptidicos.
DK0610446T3 (da) Syntetisk peptidspecificitet af antimyelin basic protein fra cerebrospinalvæske fra dissemineret sklerose
PT87537A (pt) Process for the preparation of cyclic anticoagulant peptides
DK482185D0 (da) Peptider, deres fremstilling og anvendelse som laegemidler
ES8103026A1 (es) Un procedimiento para la preparacion de un peptido
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
RU93004822A (ru) Пептиды, способ их получения, содержащее их лекарственное средство
DK255682A (da) Fremgangsmaade til fremstilling af guanidinderivater samt praeparater indeholdende disse
ATE125548T1 (de) Peptide.
ATE92078T1 (de) Pharmakologisch aktive peptide.
DK160547C (da) Fremgangsmaade til fremstilling af carboxylsyreamidgruppe-holdige forbindelser, isaer peptider
ES2081447T3 (es) Sulfonil-fenil-beta-d-tioxilosidos, su procedimiento de preparacion y su empleo en terapeutica.